Department of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Clin Immunol. 2022 Jul;240:109041. doi: 10.1016/j.clim.2022.109041. Epub 2022 May 22.
Serine and Arginine Rich Splicing Factor 1 (SRSF1) is a splicing factor that binds to exonic enhancers and stimulates splicing and is previously implicated with autoimmunity. Herein, we investigate the role of SRSF1 in regulating innate immune functions that are pertinent in the pathogenesis of auto-inflammatory diseases. Specifically, we show that conditional deletion of SRSF1 in mature lymphocytes resulted in higher expression of il-17a and il-17 f and an expansion of IL17A CD8 T cells. Mechanistically, the aberrant expression of IL-17A in SRSF1 cKO mice could not be attributed to alternative splicing of il-17a or il-17 f genes but possibly to defective CD11BLY6C myeloid derived suppressor function in the spleen. Finally, meta-analysis of RNA-Seq collected from psoriasis patients demonstrate a clear correlation between SRSF1 and psoriasis that suggests a putative role of SRSF1 in IL-17A-induced psoriasis.
丝氨酸/精氨酸丰富剪接因子 1(SRSF1)是一种剪接因子,可与外显子增强子结合并刺激剪接,先前与自身免疫有关。在此,我们研究了 SRSF1 在调节固有免疫功能中的作用,固有免疫功能与自身炎症性疾病的发病机制有关。具体来说,我们表明,成熟淋巴细胞中 SRSF1 的条件缺失导致了更高水平的 IL-17A 和 IL-17F 的表达,并导致了 IL17A CD8 T 细胞的扩增。从机制上讲,SRSF1 cKO 小鼠中 IL-17A 的异常表达不能归因于 IL-17A 或 IL-17F 基因的可变剪接,而可能是由于脾中 CD11BLY6C 髓样来源的抑制细胞功能缺陷所致。最后,对来自银屑病患者的 RNA-Seq 进行的荟萃分析表明,SRSF1 与银屑病之间存在明显的相关性,这表明 SRSF1 在 IL-17A 诱导的银屑病中可能具有作用。